These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34245948)

  • 1. Synthesis and computational studies of novel fused pyrimidinones as a promising scaffold with analgesic, anti-inflammatory and COX inhibitory potential.
    Said MF; Georgey HH; Mohammed ER
    Eur J Med Chem; 2021 Nov; 224():113682. PubMed ID: 34245948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
    Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF
    Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluations of selective COX-2 inhibitory effects: Benzo[d]thiazol analogs.
    He LY; Zhang SS; Peng DX; Guan LP; Wang SH
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127376. PubMed ID: 32738961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, modeling and biological evaluation of some pyrazolo[3,4-d]pyrimidinones and pyrazolo[4,3-e][1,2,4]triazolo[4,3-a]pyrimidinones as anti-inflammatory agents.
    Tageldin GN; Ibrahim TM; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2019 Sep; 90():102844. PubMed ID: 31229797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
    Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors.
    Gedawy EM; Kassab AE; El Kerdawy AM
    Eur J Med Chem; 2020 Mar; 189():112066. PubMed ID: 31982653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.
    Bhat MA; Al-Omar MA; Alsaif NA; Almehizia AA; Naglah AM; Razak S; Khan AA; Ashraf NM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):921-934. PubMed ID: 32238055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrazolone derivatives: synthesis, anti-inflammatory, analgesic, quantitative structure-activity relationship and in vitro studies.
    Ragab FA; Abdel-Gawad NM; Georgey HH; Said MF
    Chem Pharm Bull (Tokyo); 2013; 61(8):834-45. PubMed ID: 23902866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
    Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
    Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New pyrimido[5,4-e]pyrrolo[1,2-c]pyrimidines: synthesis, 2D-QSAR, anti-inflammatory, analgesic and ulcerogenicity studies.
    Hanna MM
    Eur J Med Chem; 2012 Sep; 55():12-22. PubMed ID: 22818041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
    Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
    Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.